W1uopvdesd27vupky6mg clyde

Clyde Biosciences Ltd.

2 Orders Completed
Newhouse, GB

About Clyde Biosciences Ltd.

Clyde Biosciences is a leading global cardiac safety service provider. Our speciality is in the assessment of cardiotoxicity potential for the global pharmaceutical industry. We work with:

  • Safety Pharmacology
  • Cardiovascular Therapeutics
  • Leading Stem Cell Suppliers

Our technology was developed in the laboratory of Professor Godfrey Smith (Chief Scientific Officer, Clyde Biosciences) a world-leading cardiac scientist with 25+ years experience in cardiac electrophysiology research. Clyde’s CellOPTIQ® platform delivers reliable, high resolution functional output from a range of cardiac cell types including iPS-derived heart cells. High bandwidth membrane voltage signals from CellOPTIQ® provides new insights into electrophysiological effects of drugs. Rapid data capture and analysis is made possible by our bespoke software which allows accelerated assay throughput in a 96 well format.

Our Services (18)


ic

In vitro Cardiotoxicity Screening

Price on request

In vitro cardiotox using iPS cardiomyocytes on a voltage sensitive dye platform. Voltage, calcium and contraction studies. Capable of running more straight forward CiPA assays through to complex mechanistic tox studies using chronic protocols. Study design and interpretation performed by Prof Smith (CSO) and data presented at a high standard for IND submission.


ic

Comprehensive in vitro Proarrhythmia Assay (CiPA)

Price on request

Clyde Biosciences is an official member of the CiPA consortium, and a Core Group member contributing towards the development of the next generation of assays.

We run drug screening studies on our CellOPTIQ® system using the accepted CiPA Protocol. Only Clyde can provide you with a rapid-turnaround VSD screening study on your compounds.

Clyde works with virtually all of the major suppliers of iPS-CMs to characterise their cells on using the standard CiPA protocol. These data provide an invaluable reference point for the performance of cells. CellOPTIQ® works with 2D and 3D structures.

Major benefits include:

  • Drug screening using a standard CiPA protocol
  • iPS-CM characterisation studies using CiPA 8 (first phase CiPA)
  • iPS-CM characterisation studies using CiPA 28 (second phase CiPA)


ic

Stem Cell Analysis and Characterization

Price on request

Clyde Biosciences works with the leading manufacturers of iPS-CMs to provide a broad dataset of parameters, enabling companies to understand the performance of their cells in the context of drug testing.

These data are essential for iPS-CM suppliers to communicate accurately the characteristics of their cells to biopharma companies.

Clyde’s Approach:

  • Clyde Biosciences’ CellOPTIQ™ system measures calcium, voltage and contractility in the same cells
  • Using ratiometric dyes, CellOPTIQ™ can make measurements which are unaffected by movement artefact or variations in cell thickness
  • This means data are more accurate, with significantly reduced signal-to-noise


ic

Ion Channel Screening Assays

Price on request

Clyde is able to provide our clients with access to the highest quality ion channel screening technology

Clyde’s Ion Channel Service:

The Rational Approach

  • Clyde partners with the industry’s leading specialist ion channel providers
  • Provide CiPA-ready data combining outputs from all assay modalities in one project


ic

Induced Pluripotent Stem Cell Lines

Price on request

hiPSC-CM - Human induced pluripotent stem cell-derived cardiomyocytes


ic

Mammalian Cell Culture

Price on request
Request a quote for more information about this service.

ic

Induced Pluripotent Stem Cell (iPSC) Culture

Price on request
Request a quote for more information about this service.

ic

Cell Line Authentication

Price on request
Request a quote for more information about this service.

ic

In silico Cardiac Safety Assessment

Price on request
Request a quote for more information about this service.

ic

Cell-Based Assays

Price on request
Request a quote for more information about this service.

ic

Cells and Tissues

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

ic

Drug Discovery & Development

Price on request

Drug Discovery & Development Services


ic

Toxicology

Price on request

Toxicology Services


ic

In vitro Toxicity Testing

Price on request

In vitro Toxicity Testing Services


ic

Pharmacology & Toxicology

Price on request
Request a quote for more information about this service.

ic

In vitro Ion Channel Assays

Price on request
Request a quote for more information about this service.

ic

Cell Lines

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
MB

Mark Bryant

Head of Business Development

Clyde Biosciences Ltd. has not received any reviews.

Clyde Biosciences Ltd. has not received any endorsements.